This post was for you to reply to posted up the forum a little. It has now been backed up by the above posted article.
NEU is not a spec stock.
It has growing earnings and milestone payments on its FDA approved drug for North America and Rest of world to come online.
It has upfronts and deals for its phase 1 completed pipeline drug globally for 2 indications. Which are soon to have results for Phase 2 trials.
But, if you can read you would know that.
I suggest you are down ramping.
I am not pumping, I am doing forward forecasts on numbers stated for Retts syndrome.
Show me yours and tell me what you come up with.
Here is your chance to contribute to the forum.
I know you wont do it. That requires some effort.
This post was for you to reply to posted up the forum a little....
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.68 |
Change
-0.100(0.48%) |
Mkt cap ! $2.643B | |||
| Open | High | Low | Value | Volume |
| $20.50 | $20.74 | $20.01 | $5.091M | 247.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 156 | $20.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.68 | 256 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |